Eric Topol

Eric Topol

Creator
0 followers

Cardiologist and digital medicine researcher; leading voice on biotech and healthcare innovation.

Microbes in Tumors: Unraveling a Controversial Role
SocialMar 12, 2026

Microbes in Tumors: Unraveling a Controversial Role

What is the significance of microbes in tumors, a field mired in controversy? https://t.co/D5sHkLLsrT https://t.co/ntGLlke4iC

By Eric Topol
RFK Jr Promotes Unproven Peptides, BPC‑157 Lacks Solid Data
SocialMar 12, 2026

RFK Jr Promotes Unproven Peptides, BPC‑157 Lacks Solid Data

RFK Jr is trying to get 14 peptides, without data on safety or efficacy, licensed and approved by FDA. His favorite is BPC-157. "Only three small human studies of BPC-157 exist, for instance, the largest of which is a telephone...

By Eric Topol
GenAI Health Tools Multiply: ChatGPT, Claude, CoPilot
SocialMar 12, 2026

GenAI Health Tools Multiply: ChatGPT, Claude, CoPilot

In January there was ChatGPT Health, Claude Health. Today there's Microsoft CoPilot Health. And more to come in the genAI -> health landscape https://t.co/TInH9YTvwA

By Eric Topol
LLMs Are Homogenizing Human Thought, Researchers Warn
SocialMar 11, 2026

LLMs Are Homogenizing Human Thought, Researchers Warn

In their paper today, the authors assert that LLMs are "homogenizing" human thought and expression https://t.co/HEaJyizbBL https://t.co/436zQieCKy

By Eric Topol
Gut Microbes Modulate Age‑related Memory and Cognition
SocialMar 11, 2026

Gut Microbes Modulate Age‑related Memory and Cognition

Gut microbes signal the brain influencing age-associated memory and cognitive function in the experimental model @arcinstitute @Nature https://t.co/elSw3RXbI9 https://t.co/6fRfCk4Z9n

By Eric Topol
GLP‑1 Drug Linked to Longer Survival in Brain Metastases
SocialMar 11, 2026

GLP‑1 Drug Linked to Longer Survival in Brain Metastases

Another potential GLP-1 drug benefit seen in people with diabetes and brain metastases for improved survival; a retrospective study that needs further assessment but intriguing https://t.co/nZm3xEYQMH https://t.co/V76S7o1MJb

By Eric Topol
Alzheimer’s Blood Markers Also Flag Certain Amyloidosis Types
SocialMar 11, 2026

Alzheimer’s Blood Markers Also Flag Certain Amyloidosis Types

The blood neuromarkers p-tau181 and p-tau217 that can predict and diagnose Alzheimer's disease are also abnormal in certain types of amyloidosis, indicating both some non-specificity and potential help in diagnosis of these conditions https://t.co/jodvMY6TNK

By Eric Topol
Severe COVID/Flu May Boost Lung Cancer Risk
SocialMar 11, 2026

Severe COVID/Flu May Boost Lung Cancer Risk

A causal link between severe Covid or flu and lung cancer risk by impairing immunity and promoting inflammation, as shown in multiple murine models https://t.co/NvE6uIYFZh

By Eric Topol
AI Augments, Not Replaces, Human Insight in Complex Biology
SocialMar 10, 2026

AI Augments, Not Replaces, Human Insight in Complex Biology

"AI will not replace biological reasoning, but it may become indispensable for navigating biological systems whose complexity exceeds human intuition." A perspective on future applications for cancer neuroscience https://t.co/TnDFZ7NRFN @scisignal https://t.co/ijbhfbjXcs

By Eric Topol
Doctors Still Beat AI on Practicality and Cost
SocialMar 10, 2026

Doctors Still Beat AI on Practicality and Cost

Comparison of AI and primary care physicians for 100 patients in a prospective real-world assessment —The physicians outperformed AI [AIME] for practicality and cost-effectiveness —AI was comparable for diagnosis, management plan, appropriateness and safety @AdamRodmanMD @alan_karthi @PeterBrodeurMD @googledeepmind https://t.co/FNWYoHVkkw

By Eric Topol
Blood Test Predicts Alzheimer's up to 25 Years Early
SocialMar 10, 2026

Blood Test Predicts Alzheimer's up to 25 Years Early

Predicting Alzheimer's disease up to 25 years in advance of any symptoms with the p-tau217 biomarker blood test, among 2,766 women mean age 70 https://t.co/aOActAUN27 https://t.co/Bxl2YZxnlf

By Eric Topol
AI Proven to Boost Breast Cancer Screening Accuracy
SocialMar 10, 2026

AI Proven to Boost Breast Cancer Screening Accuracy

3 new reports and an editorial @NatureCancer reinforce the benefit of AI for breast cancer screening https://t.co/MlFns7M0yB https://t.co/MF3fj0CuIE https://t.co/a436srKDaD https://t.co/1XTMIsAPfg

By Eric Topol
Plastic Chemical DEHP Linked to Higher Breast Cancer Risk
SocialMar 9, 2026

Plastic Chemical DEHP Linked to Higher Breast Cancer Risk

The link between exposure to DEHP and its metabolite MEHP, found in plastics, and risk of breast cancer in a 20-year prospective study https://t.co/wKEVlMxWHT https://t.co/j5NL5QfTBu

By Eric Topol
Psoriasis' Immune Activation Reduces Skin Cancer Risk
SocialMar 9, 2026

Psoriasis' Immune Activation Reduces Skin Cancer Risk

Chronic inflammation generally poses a higher risk of cancer, so why does psoriasis-like disease have a lower risk of skin cancer. Why? Sustained immune cell activation https://t.co/kcxUHC8Ahk https://t.co/igqNDv5mdj

By Eric Topol
Societal Issues Stall US Life Expectancy Growth
SocialMar 9, 2026

Societal Issues Stall US Life Expectancy Growth

Why hasn't life expectancy been increasing in the United States? It's complicated. "The fact that the United States is far from a leader in longevity and that it continues to fall further behind nearly all other high-income countries indicates that there are...

By Eric Topol
Obesity Raises Risk for Multiple Cancer Types
SocialMar 9, 2026

Obesity Raises Risk for Multiple Cancer Types

Obesity and overweight are risk factors for several types of cancer. Why? A @JAMA_current review https://t.co/fn5tfxNnsM https://t.co/caCsAt2vuB

By Eric Topol
Inactivity Kills 5 Million Annually; Policies Remain Unimplemented
SocialMar 9, 2026

Inactivity Kills 5 Million Annually; Policies Remain Unimplemented

5 million deaths a year globally are attributed to lack of physical activity. Many countries have set policies to promote physical activity but never implemented them. No improvement in >20 years! 3 new papers @NatureMedicine @NatureHealthJnl https://t.co/Nvl1AhTz2h https://t.co/hGneBJTJBO https://t.co/g94vzx3Ydu

By Eric Topol
Multivitamin Modestly Slows Epigenetic Aging; Cocoa Doesn’t
SocialMar 9, 2026

Multivitamin Modestly Slows Epigenetic Aging; Cocoa Doesn’t

Just published @NatureMedicine A daily multivitamin (MVM) slowed epigenetic aging in a randomized trial after 2 years; effect was small (~2 months) and not seen with cocoa extract supplement (vitamin was Centrum Silver) https://t.co/snOMNsTzW7 https://t.co/a6MhMuRhJb

By Eric Topol
Utah's AI Prescription Plan Faces Conflict‑of‑interest Critique
SocialMar 9, 2026

Utah's AI Prescription Plan Faces Conflict‑of‑interest Critique

Appropriate critique of Utah going with AI for prescriptions based on a @Doctronic preprint written by the company, by @JosephSakran gift link https://t.co/HcFqBy86wb https://t.co/QpVA7HGjRT

By Eric Topol
FMT Triples the Boost to Cancer Immunotherapy
SocialMar 9, 2026

FMT Triples the Boost to Cancer Immunotherapy

Not just replication, but triplication of the benefit of revving up cancer immunotherapy with FMT (Yes💩) https://t.co/rXyQdO74FJ

By Eric Topol
Add AI Breast Artery Calcification Scan to Mammograms
SocialMar 9, 2026

Add AI Breast Artery Calcification Scan to Mammograms

Mammography should include AI assessment of breast artery calcification, since it provides very useful information about cardiovascular risk https://t.co/yfTbTRrOuY https://t.co/h1C8ZnHepJ

By Eric Topol
83% Unaware of DORAs: Sleep Knowledge Gap
SocialMar 7, 2026

83% Unaware of DORAs: Sleep Knowledge Gap

There's a lot you can learn about sleep. Like 83% hadn't heard of DORAs. https://t.co/2lV3Fw6cwg https://t.co/IWRTdPTMOL

By Eric Topol
Cures for some Autoimmune Diseases Now a Reality
SocialMar 7, 2026

Cures for some Autoimmune Diseases Now a Reality

One of the most impressive advances we've ever seen for some autoimmune diseases: cures https://t.co/OZDuq4Iooy

By Eric Topol
PEP Slows Aging by Blocking Inflammation Pathway
SocialMar 6, 2026

PEP Slows Aging by Blocking Inflammation Pathway

PEP protects against age-related inflammation, puts the brake on the aging process in mice, high levels in humans correlate with low inflammation So what is PEP, you ask? phosphoenolpyruvate, from glucose metabolism, a, master regulator, blocks cGAS-STING https://t.co/glMvaHSjOq https://t.co/MSVMBJbHm4

By Eric Topol
Caloric Restriction Extends Lifespan in Animals, Human Applicability Unclear
SocialMar 6, 2026

Caloric Restriction Extends Lifespan in Animals, Human Applicability Unclear

Dietary (caloric) restriction has so many salutary effects for slowing the aging process in animal models, but whether that can be simulated in some way in people remains unclear. This new comprehensive review @NatureAging is outstanding https://t.co/xw5bmK3NaW https://t.co/t8bBmS8HGB

By Eric Topol
New Sleep Regularity Index Reveals Hidden Rest Patterns
SocialMar 6, 2026

New Sleep Regularity Index Reveals Hidden Rest Patterns

Interested in the latest sleep science and getting better quality sleep? New Ground Truths with Prof Yo-El Ju, @WashUNeurology https://t.co/2lV3Fw6cwg SRI-sleep regularity index https://t.co/zRWbVNmeap

By Eric Topol
Self‑amplifying RNA Could Protect Future Heart‑attack Patients
SocialMar 5, 2026

Self‑amplifying RNA Could Protect Future Heart‑attack Patients

Will we give a shot of protective, self-amplifying RNA in patients with a heart attack in the future? @ScienceMagazine an intriguing innovation https://t.co/FcJme1ElyU https://t.co/lABFRkR3qg

By Eric Topol
Engineered Astrocytes Use CAR‑A to Remove Amyloid Plaques
SocialMar 5, 2026

Engineered Astrocytes Use CAR‑A to Remove Amyloid Plaques

New @ScienceMagazine Engineering the brain's astrocytes to clear amyloid plaque! "CAR-A," in mouse model https://t.co/u9zJGnCLUj https://t.co/eIrrFx7iTg https://t.co/x56FDtuVW2

By Eric Topol
Aging Cells Harbor Protective Mutations That Inspire New Drugs
SocialMar 5, 2026

Aging Cells Harbor Protective Mutations That Inspire New Drugs

We're chock full of somatic mutations in our cells and tissue as we age. Some even protect us from disease! And we can learn from them to discover new medications. @CellCellPress https://t.co/mnUsarpYoR https://t.co/4c5XOD7NuC

By Eric Topol
AI Generalist Excels Across Diverse Medical Imaging Modalities
SocialMar 5, 2026

AI Generalist Excels Across Diverse Medical Imaging Modalities

Can an AI model be a generalist to work and perform well for all types of medical images? Just published, our MedVersa paper @NEJM_AI Led by @pranavrajpurkar Free access https://t.co/5llNf94hAF https://t.co/Bf01zUZ1sk

By Eric Topol
Yamanaka Stem Cells Earn Conditional Approval for Heart and Parkinson's
SocialMar 5, 2026

Yamanaka Stem Cells Earn Conditional Approval for Heart and Parkinson's

20 years of Yamanaka stem cell factor research culminates in 2 conditional approvals for heart disease and Parkinson's disease in Japan https://t.co/8oxKxXYafu by Shinya Yamanaka @CellStemCell https://t.co/U878IxSfSi @ScienceMagazine https://t.co/HCCPaTEP7e

By Eric Topol
GLP‑1 Drugs Cut Substance‑abuse Risk in Veterans
SocialMar 4, 2026

GLP‑1 Drugs Cut Substance‑abuse Risk in Veterans

Best evidence yet that GLP-1 drugs reduce the risk of substance abuse, from >600,00 US Veterans across alcohol, nicotine, opioid, cocaine, cannabis @bmj_latest @zalaly @Miao_Cai_SLU https://t.co/rcqUt0kY77

By Eric Topol
Cell‑free DNA Test Predicts Liver Disease and Mortality
SocialMar 4, 2026

Cell‑free DNA Test Predicts Liver Disease and Mortality

We've used a blood test—cell free DNA—for detecting cancer or prenatal fetal abnormalities. It turns out it can be used to detect liver diseases and all-cause mortality from other conditions @ScienceTM https://t.co/IJxPMq7hGU

By Eric Topol
AI Predicts 5‑year Health Risks From Routine CT Scans
SocialMar 4, 2026

AI Predicts 5‑year Health Risks From Routine CT Scans

When your "normal" abdominal CT tells you about the 5-year future risks that can't be seen by radiologists, but can by AI (Merlin) https://t.co/DemC983uKz https://t.co/9jqZyVTD3p

By Eric Topol
Evo 2 Open‑Source Tool Predicts Non‑Coding Pathogenicity
SocialMar 4, 2026

Evo 2 Open‑Source Tool Predicts Non‑Coding Pathogenicity

It got me at "across all domains of life" Predicting pathogenicity of non-coding regions, produces sequences at genome scale, and much more Evo 2, open-source, @Nature today @arcinstitute @pdhsu @BrianHie https://t.co/9CZWmPFhjd

By Eric Topol
Future Cancer Blood Tests May Accurately Screen High‑Risk Groups
SocialMar 4, 2026

Future Cancer Blood Tests May Accurately Screen High‑Risk Groups

Cancer blood tests for screening? Not the way they've been studied to date (age 50+) A new feature @Nature “I’m confident we’re going to see more accurate tests going forward. In high-risk groups, such as those with a genetic predisposition,...

By Eric Topol
Gut Health and Toxins Drive Parkinson’s Disease Surge
SocialMar 3, 2026

Gut Health and Toxins Drive Parkinson’s Disease Surge

The gut and environmental toxins are key underpinnings of the Parkinson's disease pandemic @jclinicalinvest https://t.co/e8o4UuIafG https://t.co/7634Yg2Qo5

By Eric Topol
LLM Medical Research Overwhelmingly Lacks Real Clinical Data
SocialMar 3, 2026

LLM Medical Research Overwhelmingly Lacks Real Clinical Data

A new systematic review of LLMs in medicine @NatureMedicine @ekoermann https://t.co/npvDeqUvel “Despite thousands [4,609] of publications since late 2022, only a small fraction use real clinical data and just 19 randomized trials exist.”

By Eric Topol
P‑tau 217 Blood Test Outperforms Total P‑tau 217 For
SocialMar 2, 2026

P‑tau 217 Blood Test Outperforms Total P‑tau 217 For

The breakthrough blood test p-tau 217 for risk and diagnosis of Alzheimer's disease is more accurate than total p-tau 217, in a head-to-head comparison using PET imaging https://t.co/faILpVr9Ua https://t.co/lzUgFnFUP5

By Eric Topol
GLP‑1 Weight‑Loss Drugs Work Better for Women
SocialMar 2, 2026

GLP‑1 Weight‑Loss Drugs Work Better for Women

A systematic RCT analysis of GLP-1 drugs show they are more effective in women than men for weight loss https://t.co/cycwi4nnN5 https://t.co/KOl0FgKaZD

By Eric Topol
AI Pathology for Cancer Markers Hindered by Shortcut Learning
SocialMar 2, 2026

AI Pathology for Cancer Markers Hindered by Shortcut Learning

AI of whole slide images for cancer molecular markers is not ready for clinical use due to confounding and biases ("shortcut learning"), supported by multiple examples @natBME https://t.co/zG8uVIxrJf https://t.co/hQ0tjiapIJ

By Eric Topol
Exercise‑derived Muscle Vesicles Boost Brain Microglia, Improve Cognition
SocialMar 2, 2026

Exercise‑derived Muscle Vesicles Boost Brain Microglia, Improve Cognition

A new mechanism for improved cognitive function from exercise in the Alzheimer's disease model Skeletal muscle EC vesicles interact with the brain and rev up microglia function https://t.co/eZu14YVasY

By Eric Topol
Antibody Plus Ozempic Drives Significant Weight Loss
SocialMar 2, 2026

Antibody Plus Ozempic Drives Significant Weight Loss

New @NatureMedicine A randomized trial of antibody vs activin type II receptors with or without semaglutide (Ozempic). The antibody, bimagrumab, promotes muscle growth. Marked weight loss with the combination https://t.co/XUK93GTAmA

By Eric Topol
Future: Real-Time Immune Monitoring Like Glucose Tracking
SocialMar 2, 2026

Future: Real-Time Immune Monitoring Like Glucose Tracking

Someday we'll be able to track our immune system like we do glucose Today @NatBME https://t.co/HFcFiUeyFg Previously @ScienceMagazine https://t.co/EcgBdwGxcd https://t.co/SpoZ5bLtjx

By Eric Topol
Accelerating CAR Engineering Shows Promising Cancer Immunotherapy
SocialFeb 28, 2026

Accelerating CAR Engineering Shows Promising Cancer Immunotherapy

Some very good news about engineering our cells vs cancer (accelerating the CAR). A short thread 1. For background, a new 5★ review on cancer immunotherapy @Cancer_Cell https://t.co/1Qz2rCs8I5 https://t.co/sJ6BwaXyjk

By Eric Topol
Smartphone AI Beats Endocrinologists in Acromegaly Diagnosis
SocialFeb 27, 2026

Smartphone AI Beats Endocrinologists in Acromegaly Diagnosis

AI is helping to make the diagnosis of rare diseases. A new multicenter study in Japan showed smartphone AI diagnosis of acromegaly via hands was better than experienced endocrinologists https://t.co/qBiazetToV https://t.co/dSZpJ2us84

By Eric Topol
Obesity Accelerates Neurodegeneration, New NatMetabolism Study Shows
SocialFeb 27, 2026

Obesity Accelerates Neurodegeneration, New NatMetabolism Study Shows

How does obesity catalyze neurodegeneration? Our paper just out @NatMetabolism https://t.co/kx25urgpJx free access https://t.co/aL1FBN9MyI Phenomenal work by @chen_bandy pulling this together

By Eric Topol
Gut Bacteria Interactions Dictate Health and Disease Risk
SocialFeb 26, 2026

Gut Bacteria Interactions Dictate Health and Disease Risk

🆕 @ScienceMagazine How gut bacteria interactions [cooperation vs competition, positive vs negative] shape risk for health and disease https://t.co/q8TvbaHDQI https://t.co/kS0S3uUIli

By Eric Topol
Immune Cells Drive Transition From Healthy Aging to Alzheimer’s
SocialFeb 26, 2026

Immune Cells Drive Transition From Healthy Aging to Alzheimer’s

What accounts for the progression from healthy aging to Alzheimer's disease over an extended period of time? The critical role of the immune system, particularly T cells and microglia. A new, excellent review @ImmunityCP https://t.co/XqEBcptTuG https://t.co/Xt24BvkDWe

By Eric Topol